Liquid biopsy

A look at the last five years of publishing on liquid biopsy

NSCLC biomarker testing can be valuable for both patient and pathologist

Spectroscopy-based liquid biopsy could offer an affordable, effective route to early brain tumor diagnosis

A new liquid biopsy test can allow easier, more accurate diagnosis of malignancy in patients who are predisposed to cancer

Adding new biomarkers to existing tests could give us a better view of the brain and the degenerative diseases that affect it

Could a new prototype biosensor challenge the current gold standard method of breast cancer detection?

Reliably stratifying patients with spinal cord injury is essential for optimal treatment – and serum cytokines may be the key

Using a simple blood test to identify the tissue source and genes of dead cells may be a step forward for noninvasive biopsies

With better assays comes the need for better controls – are liquid biopsies and cell line-derived controls a match made in heaven?

Results presented at IASLC 2020 highlight the promising role of liquid biopsy in non-small cell lung carcinoma testing